Brief: Moberg Pharma: Rights Issue Is Oversubscribed

Moberg Pharma AB (publ)

01/09/2023 12:02

Sept 1 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA'S RIGHTS ISSUE OF MSEK 100 IS OVERSUBSCRIBED
-
SUBSCRIPTION RATE 130%
    * MOBERG PHARMA WILL RECEIVE APPROXIMATELY SEK 100 MILLION
BEFORE
DEDUCTION FOR TRANSACTION COSTS.
    * SHARE CAPITAL WILL INCREASE BY SEK 17,470,149.867306 TO A
TOTAL
OF SEK 27,743,083.377306
    * NUMBER OF SHARES IN COMPANY WILL INCREASE BY 17,470,149 TO
A
TOTAL OF 27,743,082
    * THIS ENTAILS A DILUTION EFFECT OF APPROXIMATELY 63
PERCENT.

Source text for Eikon:  ID:nWkr5lrlkD 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))